CHRS logo

Coherus BioSciences (CHRS)

Profile

Full Name

Coherus BioSciences, Inc.

Ticker Symbol

CHRS

Exchange

NASDAQ

Country

United States

IPO

November 6, 2014

Indexes

Not included

Employees

228

Key Details

Price

$1.12(+10.89%)

Market cap

$129.80M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$266.96M(+3.78% YoY)

Annual EPS

$0.25(+109.88% YoY)

PE ratio

5.89

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 11, 25 HC Wainwright & Co.
Buy
Jan 23, 25 HC Wainwright & Co.
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Dec 5, 24 Baird
Outperform
Dec 4, 24 HC Wainwright & Co.
Buy
Nov 8, 24 Baird
Outperform
Nov 7, 24 HC Wainwright & Co.
Buy
Sep 16, 24 HC Wainwright & Co.
Buy
Aug 16, 24 UBS
Neutral
Aug 5, 24 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Coherus BioSciences?
  • Does Coherus BioSciences pay dividends?
  • What sector is Coherus BioSciences in?
  • What industry is Coherus BioSciences in?
  • What country is Coherus BioSciences based in?
  • When did Coherus BioSciences go public?
  • Is Coherus BioSciences in the S&P 500?
  • Is Coherus BioSciences in the NASDAQ 100?
  • Is Coherus BioSciences in the Dow Jones?
  • When was Coherus BioSciences's last earnings report?
  • When does Coherus BioSciences report earnings?
  • Should I buy Coherus BioSciences stock now?

What is the ticker symbol for Coherus BioSciences?

The ticker symbol for Coherus BioSciences is NASDAQ:CHRS

Does Coherus BioSciences pay dividends?

No, Coherus BioSciences does not pay dividends

What sector is Coherus BioSciences in?

Coherus BioSciences is in the Healthcare sector

What industry is Coherus BioSciences in?

Coherus BioSciences is in the Biotechnology industry

What country is Coherus BioSciences based in?

Coherus BioSciences is headquartered in United States

When did Coherus BioSciences go public?

Coherus BioSciences's initial public offering (IPO) was on November 6, 2014

Is Coherus BioSciences in the S&P 500?

No, Coherus BioSciences is not included in the S&P 500 index

Is Coherus BioSciences in the NASDAQ 100?

No, Coherus BioSciences is not included in the NASDAQ 100 index

Is Coherus BioSciences in the Dow Jones?

No, Coherus BioSciences is not included in the Dow Jones index

When was Coherus BioSciences's last earnings report?

Coherus BioSciences's most recent earnings report was on Mar 10, 2025

When does Coherus BioSciences report earnings?

The next expected earnings date for Coherus BioSciences is May 9, 2025

Should I buy Coherus BioSciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page